Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02103621 · ClinicalTrials.gov registry record · NA
Assisting Obsessive Compulsive Disorder (OCD) Patients With Discontinuing Long-term Serotonin Reuptake Inhibitors (SRIs)
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02103621 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 14 participants.
The verdict
NCT02103621, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will address questions of fundamental clinical significance including: (1) whether OCD patients maintained on long term SRIs can be discontinued without symptom exacerbation, (2) whether trans-diagnostic cognitive-behavioral treatment will reduce worsening following discontinuation compared to Taper and Monitoring, and (3) whether predictors of successful SRI discontinuation can be identified.
Interventions
- BEHAVIORAL Unified Protocol (UP)
- BEHAVIORAL Taper and Monitoring (TAP-M)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02103621
The ClinicalTrials.gov registry entry for NCT02103621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Unified Protocol (UP) is the first listed.
NCT02103621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02103621 about?
NCT02103621 is a clinical study titled "Assisting Obsessive Compulsive Disorder (OCD) Patients With Discontinuing Long-term Serotonin Reuptake Inhibitors (SRIs)". This study will address questions of fundamental clinical significance including: (1) whether OCD patients maintained on long term SRIs can be discontinued without symptom exacerbation, (2) whether trans-diagnostic cognitive-behavioral treatment will reduce worsening following discontinuation compar...
What is the current status of trial NCT02103621?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2014-05. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02103621?
The interventions under investigation include: Unified Protocol (UP) (BEHAVIORAL), Taper and Monitoring (TAP-M) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02103621?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.